Indoleamine 2,3-dioxygenase in psoriasis: a defective mechanism

被引：2
|
作者：
Trabanelli, S. [1 ]
机构：
[1] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 176卷 / 03期
关键词：
T REGULATORY CELLS; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; EXPRESSION; TOLERANCE;
D O I：
10.1111/bjd.15097
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [21] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [22] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [23] Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia
    Sobash, Philip T.
    Kolhe, Ravindra
    Karim, Nagla Abdel
    Guddati, Achuta K.
    Jillella, Anand
    Kota, Vamsi
    FUTURE ONCOLOGY, 2020, 16 (36) : 3085 - 3094
  • [24] Tumor immune escape mediated by indoleamine 2,3-dioxygenase
    Zamanakou, Maria
    Germenis, Anastasios E.
    Karanikas, Vaios
    IMMUNOLOGY LETTERS, 2007, 111 (02) : 69 - 75
  • [25] Novel candesartan derivatives as indoleamine 2,3-dioxygenase inhibitors
    Matsuno, Kenji
    Yamazaki, Hiroshi
    Isaka, Yoshinobu
    Takai, Kazushige
    Unno, Yuka
    Ogo, Naohisa
    Ishikawa, Yoshinobu
    Fujii, Satoshi
    Takikawa, Osamu
    Asai, Akira
    MEDCHEMCOMM, 2012, 3 (04) : 475 - 479
  • [26] Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children
    Buyuktiryaki, B.
    Sahiner, U. M.
    Girgin, G.
    Birben, E.
    Soyer, O. U.
    Cavkaytar, O.
    Cetin, C.
    Yilmaz, E. Arik
    Yavuz, S. T.
    Kalayci, O.
    Baydar, T.
    Sackesen, C.
    ALLERGY, 2016, 71 (02) : 258 - 266
  • [27] Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
    Song, Xiaotian
    Si, Qianqian
    Qi, Rui
    Liu, Weidan
    Li, Miao
    Guo, Mengyue
    Wei, Lin
    Yao, Zhiyan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection
    Heller, M. C.
    Drew, C. P.
    Jackson, K. A.
    Griffey, S.
    Watson, J. L.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2010, 138 (03) : 174 - 182
  • [29] Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis
    Suzuki, Yuzo
    Suda, Takafumi
    Asada, Kazuhiro
    Miwa, Seiichi
    Suzuki, Masako
    Fujie, Michio
    Furuhashi, Kazuki
    Nakamura, Yutaro
    Inui, Naoki
    Shirai, Toshihiro
    Hayakawa, Hiroshi
    Nakamura, Hirotoshi
    Chida, Kingo
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (03) : 436 - 442
  • [30] Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
    Lindstrom, Vesa
    Aittoniemi, Janne
    Jylhava, Juulia
    Eklund, Carita
    Hurme, Mikko
    Paavonen, Timo
    Oja, Simo S.
    Itala-Remes, Maija
    Sinisalo, Marjatta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (05) : 363 - 365
12345